Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

DiscoveRX

Explore full profile

Company developing, manufacturing, and commercializing reagents

Fremont, United StatesFounded 2000Biotech & Life Sciences
Valuation $25–50M Last recorded · 2010
Headcount 100–500 Current team size
Total funding $10–50M Disclosed equity funding
Unlock exact values This page shows ranges. Dealroom has the exact numbers for DiscoveRX and the history behind them.

About DiscoveRX

DiscoverX Corporation is a prominent supplier of innovative cell-based assays and services tailored for drug discovery and development. Operating in the pharmaceutical and biotechnology sectors, DiscoverX serves a diverse range of clients including pharmaceutical companies, biotech firms, and academic research institutions. The company specializes in providing high-throughput screening solutions, which are essential for identifying and optimizing drug candidates. DiscoverX's business model revolves around offering proprietary assay technologies and services that enable clients to accelerate their drug development processes. Revenue is generated through the sale of assay kits, custom assay development services, and licensing of proprietary technologies. The company’s offerings are designed to provide physiologically relevant data, which is crucial for making informed decisions in the early stages of drug development. DiscoverX's market position is strengthened by its extensive portfolio of products and services, which include cell-based screening, biochemical screening, and phenotypic profiling. The company is committed to innovation and sustainability, as evidenced by its efforts to reduce, reuse, and recycle in its operational practices.

Source: Dealroom company data

At a glance

Founded
2000
Headquarters
Fremont, United States
Sector
Biotech & Life Sciences

Investors

1 investor on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A1 investor entered at this stage

  • Morgan Stanley Expansion Capital
Team profiled 16 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 2 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
5 countries with
team presence
🇺🇸 United States91%
🇬🇧 United Kingdom3.9%
🇫🇷 France2.6%
🇩🇪 Germany1.3%
🇨🇳 China1.3%
5 countries shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about DiscoveRX on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See DiscoveRX on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.